Please provide your email address to receive an email when new articles are posted on . The study included 227 individuals with OUD given CAM2038 either on weekly or monthly basis. The treatment was ...

The findings, which appeared today in JAMA Network Open, are strong evidence that buprenorphine, a medication approved by the U.S. Food and Drug Administration to treat opioid use disorder, can be ...

Buprenorphine, an evidence-based treatment for opioid use disorder, is currently underprescribed because of concerns that it can cause ‘precipitated withdrawal’, in which the first dose causes sudden, ...

Ever since fentanyl came to dominate the U.S. illicit drug supply, doctors and patients have found buprenorphine, a key addiction-treatment medication, increasingly difficult to use. All too often, ...

Among 100 adult patients with minimal-to-mild opioid withdrawal scores who were given a 24-mg dose of extended-release buprenorphine, only 10 people (10%, 95% CI 4.9% ...

Cooper Health expands its Bupe FIRST program to Newark and Paterson, bringing lifesaving buprenorphine treatment to more ...

Iatrogenic physical dependence has been documented in human infants infused i.v. with fentanyl or morphine to maintain continuous analgesia and sedation during extracorporeal membrane oxygenation and ...

Twenty-four percent of US adolescent treatment centers do not use a “lifesaving” medication. An article appeared today in the Journal of the American Medical Association titled “Treatments Used Among ...

Hospital stays for infants experiencing opioid withdrawal after exposure to the narcotics in utero can be greatly reduced by treatment with buprenorphine, according to a study published in The New ...